City of Hope Reveals Vision for World-Class Cancer Care in Orange County

June 25, 2019 | City of Hope

City of Hope has accelerated its plans for a $1 billion comprehensive cancer campus in Orange County, bringing highly specialized cancer care, clinical trials, precision medicine and early detection to the nation’s sixth most populous county.

Continue Reading

CAR T for CNS lymphoma: Early research shows promise

December 12, 2018 | Cara Martinez

Xiuli Wang, Ph.D., research professor at City of Hope, presented encouraging research on using CAR T cell therapy for central nervous system lymphoma at this year's American Society of Hematology conference.

City of Hope investigators present breakthrough research at 60th American Society of Hematology meeting

December 5, 2018 | Letisia Marquez

Physicians and researchers at the 2018 American Society of Hematology conference presented clinical trials for new leukemia and lymphoma treatments, laying the groundwork for innovative therapeutic approaches aimed at improving treatment options and quality of life for patients.

Researcher awarded grant to study promising new HIV therapy

October 18, 2018 | Samantha Bonar

The California Institute for Regenerative Medicine has awarded City of Hope’s Xiuli Wang, Ph.D., $3.8 million to develop chimeric antigen receptor (CAR) T cells that can target and kill HIV-infected cells.

Parker Institute for Cancer Immunotherapy Welcomes Stephen J. Forman, M.D.

September 27, 2018 | Letisia Marquez

City of Hope’s Stephen J. Forman, M.D., is now an official member of the Parker Institute for Cancer Immunotherapy.

City of Hope's Stephen J. Forman Joins Parker Institute for Cancer Immunotherapy

July 16, 2018 | Letisia Marquez

City of Hope’s CAR T research and treatment team is now an official member of the Parker Institute for Cancer Immunotherapy.

Meet the CAR T Team: Xiuli Wang, Ph.D.

January 4, 2018 | Maxine Nunes

Xiuli Wang, Ph.D., is at the forefront of one of the most exciting breakthroughs in cancer treatment, chimeric antigen receptor (CAR) T cell therapy.

CAR T Cell Trial for Multiple Myeloma to Launch in 2017

March 22, 2017 | Travis Marshall

CAR T cell therapy research at City of Hope is an innovative and promising approach that recruits the body’s own immune system in the fight against some of the hardest-to-treat cancers, including multiple myeloma.